GMO (Jeremy Grantham) — NVS Trade History
Quarter-by-quarter changes in the NOVARTIS AG position · CUSIP 66987V109
Currently held · 3.8 YearsFirst seen: 2018 Q2split-adjusted
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Reduce | 245,957 | -29,680 | -10.8% | $38.5M | 0.09% |
| 2026 Q1 | 2026-05-14 | Reduce | 275,637 | -23,538 | -7.9% | $42.1M | 0.11% |
| 2025 Q4 | 2026-02-17 | Reduce | 299,175 | -31,857 | -9.6% | $41.2M | 0.10% |
| 2025 Q3 | 2025-11-13 | Reduce | 331,032 | -21,663 | -6.1% | $42.5M | 0.12% |
| 2025 Q2 | 2025-08-13 | Reduce | 352,695 | -39,456 | -10.1% | $42.7M | 0.13% |
| 2025 Q1 | 2025-05-14 | Reduce | 392,151 | -185,750 | -32.1% | $43.7M | 0.14% |
| 2024 Q4 | 2025-02-13 | Reduce | 577,901 | -87,118 | -13.1% | $56.2M | 0.18% |
| 2024 Q3 | 2024-11-13 | Reduce | 665,019 | -114,662 | -14.7% | $76.5M | 0.24% |
| 2024 Q2 | 2024-08-13 | Reduce | 779,681 | -166,195 | -17.6% | $83.0M | 0.28% |
| 2024 Q1 | 2024-05-14 | Reduce | 945,876 | -581,499 | -38.1% | $91.5M | 0.33% |
| 2023 Q4 | 2024-02-13 | Reduce | 1,527,375 | -299,888 | -16.4% | $154.2M | 0.68% |
| 2023 Q3 | 2023-11-13 | Add | 1,827,263 | 1,144,307 | +167.6% | $186.1M | 0.88% |
| 2023 Q2 | 2023-08-14 | Add | 682,956 | 672,756 | +6595.6% | $68.9M | 0.32% |
| 2023 Q1 | 2023-05-12 | Reduce | 10,200 | -34,800 | -77.3% | $938.4K | 0.01% |
| 2022 Q4 | 2023-02-13 | New | 45,000 | 45,000 | — | $4.1M | 0.02% |
| 2022 Q3 | 2022-11-10 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-12 | Sold out | — | -3,500 | -100.0% | — | — |
| 2022 Q1 | 2022-05-13 | Reduce | 3,500 | -192,200 | -98.2% | $307.0K | 0.00% |
| 2021 Q4 | 2022-02-11 | Add | 195,700 | 32,800 | +20.1% | $17.1M | 0.08% |
| 2021 Q3 | 2021-11-12 | Add | 162,900 | 159,900 | +5330.0% | $13.3M | 0.07% |
| 2021 Q2 | 2021-08-12 | New | 3,000 | 3,000 | — | $274.0K | 0.00% |
| 2021 Q1 | 2021-05-13 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-13 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | Sold out | — | -4,500 | -100.0% | — | — |
| 2019 Q2 | 2019-08-13 | Reduce | 4,500 | -2,308 | -33.9% | $411.0K | 0.00% |
| 2019 Q1 | 2019-05-14 | Reduce | 6,808 | -4,910 | -41.9% | $586.0K | 0.00% |
| 2018 Q4 | 2019-02-13 | Reduce | 11,718 | -7,366 | -38.6% | $901.0K | 0.01% |
| 2018 Q3 | 2018-11-14 | Reduce | 19,084 | -2,678 | -12.3% | $1.5M | 0.01% |
| 2018 Q2 | 2018-08-14 | New | 21,762 | 21,762 | — | $1.5M | 0.01% |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-13 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-10 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.